Randomaized clinical trial to compare Dostinex versus Quinagolide to prevention of ovarian hyperstimulation syndrome

Trial Profile

Randomaized clinical trial to compare Dostinex versus Quinagolide to prevention of ovarian hyperstimulation syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Apr 2017

At a glance

  • Drugs Cabergoline (Primary) ; Quinagolide (Primary)
  • Indications Ovarian hyperstimulation syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Apr 2017 New trial record
    • 02 Mar 2017 Recruitment status is completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top